Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study

This publication has 14 references indexed in Scilit:

• SEVERE SULFADIAZINE HYPERSENSITIVITY IN A CHILD WITH REACTIVATED CONGENITAL TOXOPLASMIC CHORIORETINITIS
  The Pediatric Infectious Disease Journal, 2006
• Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
• Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening
  American Journal of Obstetrics and Gynecology, 2005
• Congenital Toxoplasmosis Transmitted from an Immunologically Competent Mother Infected Before Conception
  Clinical Infectious Diseases, 1996
• Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis.
  Radiology, 1996
• Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment Trial
  Clinical Infectious Diseases, 1994
• Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group
  Antimicrobial Agents and Chemotherapy, 1992
• RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSIS
  The Lancet, 1986
• New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A
  Antimicrobial Agents and Chemotherapy, 1984
• Intellectual deficits in children born withsubclinical congenital toxoplasmosis: A preliminary report
  The Journal of Pediatrics, 1973